Drug Coverage In Exchange Plans Should Be On Par With Other "Essential Benefits," PhRMA Tells IoM

PhRMA was among a number of stakeholders presenting comments Jan. 14 to the committee on criteria and methods for determining and updating what qualifies as "essential health benefits" in the exchange plans.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet